Dna Group (T.R.) Ltd (TLV:DNA)

Market Cap	133.26M
Revenue (ttm)	306.00K
Net Income (ttm)	15.05M
Shares Out	123.16M
EPS (ttm)	0.12
PE Ratio	8.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,216
Average Volume	102,457
Open	110.10
Previous Close	110.10
Day's Range	107.00 - 110.10
52-Week Range	59.00 - 118.90
Beta	0.19
RSI	59.43
Earnings Date	Mar 26, 2025

About Dna Group (T.R.)

Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral dr...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: Israel
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: DNA

Financial Performance

In 2023, Dna Group (T.R.)'s revenue was 306,000, a decrease of -45.36% compared to the previous year's 560,000. Losses were -1.18 million, -95.00% less than in 2022.